Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46f1fbaa74e47e35594055d95a50319c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1de26f20930e770a4cfabc2e464c629 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad4db02e46a696e879c60291ae94b461 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31fb964e2148aff14f5bfc5f5ae6fbaf |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16234 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
filingDate |
2008-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e5d70bae029c0b3e3580ee670fadca1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c864489814f0e3faf8ce32ffa76013af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c31b53d6c1f2e2c57a2a680437a87130 |
publicationDate |
2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009046497-A1 |
titleOfInvention |
Method of eliciting an immune response against pandemic influenza virus |
abstract |
A method for eliciting or inducing a protective immune response in a subject against a pandemic subtype of influenza virus comprises administering to the subject a composition comprising (i) at least one immunogen of an endemic influenza subtype, and (ii) an immunogen-free immunostimulating complex as adjuvant. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736958-B2 |
priorityDate |
2007-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |